We found that MTAP-ANRIL overexpression in melanoma cells inhibited the expression of MTAP and decreased the expression of E-cadherin but increased the expression of N-cadherin, important markers of EMT. The gene discussed is CDKN2B-AS1; the disease is melanoma.